Clinical Trial Update: Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase II trial of a Hedgehog pathway inhibitor in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Hedgehog pathway inhibitor

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 2 | Status: COMPLETED | Results posted: 2017-03-14